Safe use of compounded GLP products
US$ 22.09
retatrutide and semaglutide vs Ozempic: Why the Weight Loss Gap Is So Large Retatrutide vs. semaglutide: A head-to-head
Description
Pricing is current as of May 2026 and may change
A July 2024 Harvard study found diabetes patients prescribed semaglutide were over four times likely to develop NAION, while those prescribed it for weight loss were over seven times likely to develop this condition
It is a straightforward process but far removed from the medical oversight and FDA-approved medications offered at true GLP-1 clinics
However, the same Authors in the second study, failed to demonstrate a reduction in HOMA-IR, fasting glucose and insulin and glucose and insulin during OGTT in both treated groups [58]
